Mats Hansen, CEO Spago Nanomedical: How to Lead a Radiotherapy Biotech episode artwork

EPISODE · Apr 1, 2024 · 37 MIN

Mats Hansen, CEO Spago Nanomedical: How to Lead a Radiotherapy Biotech

from A Dose of Reality with Charles Spence

In this episode, we explore radiotherapy biotech with Mats Hansen. He is the CEO of Spago Nanomedical AB, a biotech firm advancing cancer treatment with new radiopharmaceuticals. Mats discusses the challenges and opportunities in the radiopharmaceutical space and provides insights into nanomedical radiopharmaceuticals for cancer treatment using lutetium-177. He also shares his experiences and insights on leadership and communication skills, emphasizing the importance of effective communication in leadership roles, and discusses how his approach to leadership has evolved over the years.Here's what you are in for: 00:00 Introduction05:08 - Experience in Drug Development 13:19 - The Role of AI on Pharma and BioTech15:19 - Spargo Nanomedical and Recent Developments23:15- Challenges and Opportunities in Radiopharmaceutical Space25:48 - Considerations for Investors 31:19 - Challenges and Growth as a CEOABOUT MATSMats Hansen, a scientist from southern Sweden, loves nature deeply and is curious and passionate about science. These driving forces propelled him to pursue a career in science and pharmaceutical development. Mats has come a long way, from his start in plant breeding and working with molecular markers to now being the CEO of Spago Nanomedical AB. By applying scientific knowledge in an industrial setting, he has adeptly navigated the challenges of drug development, continuously refining his skills in communication and leadership along the way. Connect with Mats on:LinkedIn: inkedin.com/in/matshansen1 Website: spagonanomedical.se  ABOUT CHARLESCharles Spence leads Discera, a leading recruitment firm specializing in the biopharma industry. He graduated with a biomedical degree, has worked in hospitals (including translation work in Seoul, South Korea) and also spent years doing research in diabetes. After doing research and travel, a career in business and science felt the most appropriate.In 2023, Charles decided to launch his firm - Discera Search. A firm committed to solving the biggest talent needs of Early clinical stage SME biotechs on the East Coast and DACH.Connect with Charles:LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/ Website: https://www.discera-search.com/

Episode metadata supplied by the publisher feed · Published Apr 1, 2024

Embed this episode

NOW PLAYING

Mats Hansen, CEO Spago Nanomedical: How to Lead a Radiotherapy Biotech

0:00 37:57

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of A Dose of Reality with Charles Spence?

This episode is 37 minutes long.

When was this A Dose of Reality with Charles Spence episode published?

This episode was published on April 1, 2024.

Can I download this A Dose of Reality with Charles Spence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!